Epstein Secrets

result with this method. Prostate—Specific Ag, Serum Prostate Specific Ag, Serum 0.7 ng/mL 0.0 - 4.0 01 Roche ECLIA methodology. According to the American Urological Association, Serum PSA should decrease and remain at undetectable levels after radical prostatectomy. The AUA defines biochemical recurrence as an initial PSA

ve Negative Negative Negative Negative 0.2 Negative FLAG UNITS RICTERENCE INTERVAL IAS Protein Glucose Ketones Occult Blood Bilirubin Urobilinogen,Semi-On Nitrite, Urine Microscopic Examination Microscopic follows if indicated. Lipid Panel With LDL/HDL Ratio Cholesterol, Total Triglyceride

ITS REFERENCE INTERVAL LAB Prostate-Specific Ag, Serum Prostate Specific Ag, Serum Roche ECLIA methodology. 0.6 ng/mL 0.0 - 4.0 According to the American Urological Association, Serum PSA should decrease and remain at undetectable levels after radical prostatectomy. The AUA defines biochemical recurrence as an initial PSA

sis, Routine Urinalysis Gross Exam specific Gravity PH Urine-Color Appearance WBC Esterase Protein Glucose Ketones Occult Blood Bilirubin Urobilinogen,Semi-Qn Nitrite, Urine 1.028 5.5 Yellow Clear Negative Negative Negative Negative Trace Negative 0.2 Negative Abnormal EU/dL 10 22

257-S80-2371D Date collected:09/14/2018 1255 Local TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB TSH Roche ECLIA methodology. According to the American Urological Association, Serum PSA should decrease and remain at undetectable levels after radical prostatectomy. The AUA defines biochemical recurrence as an initial PSA

sis, Routine Urinalysis Gross Exam Specific Gravity pH Urine-Color Appearance WBC Esterase Protein Glucose Ketones Occult Blood Bilirubin Urobilinogen,Semi-Con Nitrite, Urine Microscopic Examination Microscopic follows PE+Interp(Rfx IFE),S mg/dL g/dL g/dL g/dL mg/dL IU/L 26 IU/L 37 IU/